A Reliable & Flexible Technology for the Rapid Conjugation of Antibodies & Other Biologics

Time: 9:45 am
day: Conference Day Two


  • Describing how Singzyme provides a one-stop solution for antibodies and nanobodies engineering and conjugation
  • Exploring how Singzyme’s technology accelerates the development of cancer immunotherapy, allowing faster production of antibody-drug-conjugates with minimal footprint on the final product and the possibility to attach two payloads with a defined DAR
  • Exploring Singzyme’s technology which allows imaging for disease diagnosis: production of radiopharmaceuticals for PET scan imaging (Nanobodies or mAbs) with minimal radioactive waste thanks to the highest conjugation efficiency on the market